IVERIC Bio
(NASDAQ) ISEE
This security has been delisted. This page is retained for historical reference.
ISEE News
Fovista Flops: What's Next?
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowISEE Financials
Key Financial Metrics (TTM)
Gross Margin
0%
Operating Margin
0%
Net Income Margin
0%
Return on Equity
-39%
Return on Capital
-30%
Return on Assets
-26%
Earnings Yield
N/A
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
N/A
Shares Outstanding
N/A
Volume
N/A
Avg. Volume
N/A
Financials (TTM)
Gross Profit
$0.00
Operating Income
$189.91M
EBITDA
$192.28M
Operating Cash Flow
$163.77M
Capital Expenditure
$736.00K
Free Cash Flow
$164.51M
Cash & ST Invst.
$646.84M
Total Debt
$97.77M
IVERIC Bio Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
N/A
Gross Profit
$0.00
N/A
Gross Margin
0.00%
N/A
Market Cap
N/A
N/A
Market Cap/Employee
N/A
N/A
Employees
163
N/A
Net Income
$70.62M
-104.5%
EBITDA
$73.77M
-114.6%
Quarterly Fundamentals
Net Cash
$502.16M
+45.8%
Accounts Receivable
$0.00
N/A
Inventory
$0.00
N/A
Long Term Debt
$96.99M
+25091.4%
Short Term Debt
$774.00K
-19.0%
Return on Assets
-26.36%
N/A
Return on Invested Capital
-30.08%
N/A
Free Cash Flow
$50.83M
-35.1%
Operating Cash Flow
$50.59M
-34.9%